Evidence map›Paper›PMID 42160320›Full record

ArticlePLoS neglected tropical diseases2026

How rash and eschar came to clinical attention in scrub typhus and Japanese spotted fever.

Eiichiro Sando, Ikkoh Yasuda

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eiichiro SandoDepartment of Infection Control, Fukushima Medical University, Fukushima, Japan.
Ikkoh YasudaDepartment of Infection Control, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0002-4503-5579

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly diagnosis of scrub typhus and Japanese spotted fever remains challenging because initial manifestations are often nonspecific. In endemic areas, nearly 30% of patients were not correctly diagnosed at the first visit to a participating site. Previous studies have mainly treated rash and eschar as present-or-absent findings. We examined how rash and eschar came to clinical attention in patients correctly diagnosed at the first visit to a participating site and in those diagnosed later. METHODOLOGY/PRINCIPAL

findingsWe analyzed 217 patients with scrub typhus or Japanese spotted fever from three healthcare facilities in an endemic region of Japan. Because first-visit documentation was incomplete in many delayed-diagnosis cases, recognition-pattern variables were abstracted at the time the correct diagnosis was established. Among these patients, 156 (71.9%) were correctly diagnosed at the first visit to a participating site and 61 (28.1%) were diagnosed after one or more subsequent visits. In multivariable analysis, correct first-visit diagnosis was associated with rash reported as a chief complaint (adjusted odds ratio [aOR] 4.95, 95% confidence interval [CI] 2.07-11.84), rash elicited during history taking (aOR 5.86, 95% CI 2.80-12.27), eschar identified on physical examination (aOR 2.80, 95% CI 1.19-6.58), and eschar elicited during history taking, which was exclusively observed among patients diagnosed at the first visit to a participating site. Age 75 years or older was associated with lower odds of correct first-visit diagnosis (aOR 0.40, 95% CI 0.21-0.75). CONCLUSIONS/SIGNIFICANCE: In endemic settings, patients correctly diagnosed at the first visit to a participating site more often had rash and eschar brought to clinical attention in specific ways. Directed inquiry about skin symptoms and careful examination for eschar may help recognition in routine care.

Indexed as

ExanthemaScrub TyphusSpotted Fever Group RickettsiosisAdolescentAdultAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedYoung Adult

Identifiers

PMID42160320
PMCPMC13197070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.